SCF antibody compositions and methods of using the same
Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
1. A purified antibody that is specifically immunoreactive with a stem cell factor (SCF).
2. The purified antibody of claim 1 , wherein said antibody is a monoclonal antibody.
3. The purified antibody of claim 1 , wherein said antibody is specifically immunoreactive with human SCF.
4. The purified antibody of claim 1 , wherein said antibody is specifically immunoreactive with a non-human vertebrate SCF.
5. The purified antibody of claim 1 , wherein said antibody is specifically immunoreactive with an SCF factor comprising the sequence of SEQ ID NO:44, SEQ ID NO: 46, or SEQ ID NO: 61.
6. The purified antibody of claim 1 , wherein said antibody is specifically immunoreactive with a non-human SCF factor comprising the sequence of any of the sequences set out in SEQ ID NOs: 49–57.
7. A hybridoma cell line producing a monoclonal antibody that is specifically immunoreactive with a stem cell factor protein.
8. A composition comprising: i) an antibody specifically immunoreactive with an SCF polypeptide; and ii) an acceptable carrier excipient or diluent.